KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Biolife Solutions (BLFS) Notes Payables (2016)

Historic Notes Payables for Biolife Solutions (BLFS) over the last 1 years, with Q4 2016 value amounting to $2.8 million.

Biolife Solutions' Notes Payables changed N/A to $2.8 million in Q4 2016 from the same period last year, while for Dec 2016 it was $2.8 million, marking a year-over-year change of. This contributed to the annual value of $2.8 million for FY2016, which is N/A changed from last year.
As of Q4 2016, Biolife Solutions' Notes Payables stood at $2.8 million.
Biolife Solutions' Notes Payables' 5-year high stood at $2.8 million during Q4 2016, with a 5-year trough of $656809.0 in Q2 2016.